Predictive Oncology’s Novel Approach to Abandoned Drugs
Predictive Oncology leveraged its AI-driven drug discovery platform and biobank of live-cell tumor samples to identify new potential uses...
eClinical Tech News
BioCardia Starts CardiAMP HF II Patient Enrollment at Emory
BioCardia announced that Emory University School of Medicine is enrolling patients in the Phase III CardiAMP HF II trial,...
Verve Therapeutics Gets FDA Fast Track for PCSK9 Gene Editing Medicine
Verve Therapeutics has received FDA Fast Track designation for VERVE-102, a gene editing medicine designed as a single-course treatment...
Folia Health Launches C3G Study on Rare Renal Disease Impact
Folia Health has launched an at-home study for individuals with C3 glomerulopathy (C3G) in partnership with Novartis. The study...
Clearmind Medicine Initiates U.S. Clinical Trial for Alcohol Use Disorder
Clearmind Medicine Inc. has launched a Phase I/IIa clinical trial for its novel Alcohol Use Disorder (AUD) treatment, CMND-100,...
Riva Biologics Presents Positive Syn-004 Data in Allo-HCT
Theriva Biologics announced the presentation of interim safety and pharmacokinetic data from its ongoing Phase 1b/2a clinical trial of...
Grace Therapeutics and FDA Align on GTX-104 NDA Submission
Grace Therapeutics, a late-stage biopharmaceutical company, announced positive feedback from the FDA regarding its planned New Drug Application (NDA)...
Context Therapeutics Doses First Patient in Phase 1 Trial of CT-95
Context Therapeutics has dosed the first patient in a Phase 1 clinical trial for CT-95, a bispecific antibody targeting...
Digital Lung Simulations in Pulmonary Fibrosis Drug Development
Ebenbuild’s Twinhale technology, a software for creating digital lung twins, was used in a preclinical study on idiopathic pulmonary...
Inna-051 Antiviral Phase 2 Study: Respiratory Disease Breakthrough
ENA Respiratory is partnering with the University of Maryland’s Center for Vaccine and Global Development (CVDGH) to conduct a...